These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3275896)

  • 81. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
    Mathew JM; H-Voss J; LeFever A; Konieczna I; Stratton C; He J; Huang X; Gallon L; Skaro A; Ansari MJ; Leventhal JR
    Sci Rep; 2018 May; 8(1):7428. PubMed ID: 29743501
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.
    Carrero JJ; Hecking M; Chesnaye NC; Jager KJ
    Nat Rev Nephrol; 2018 Mar; 14(3):151-164. PubMed ID: 29355169
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation.
    Bornemann K; Croswell E; Abaye M; Bryce CL; Chang CH; Good DS; Freehling Heiles CA; Dew MA; Boulware LE; Tevar AD; Myaskovsky L
    Contemp Clin Trials; 2017 Feb; 53():52-59. PubMed ID: 27923612
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Disparities in completion rates of the medical prerenal transplant evaluation by race or ethnicity and gender.
    Monson RS; Kemerley P; Walczak D; Benedetti E; Oberholzer J; Danielson KK
    Transplantation; 2015 Jan; 99(1):236-42. PubMed ID: 25531896
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Medicare's End Stage Renal Disease Program.
    Eggers PW
    Health Care Financ Rev; 2000; 22(1):55-60. PubMed ID: 25372768
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis.
    Schold JD; Buccini LD; Goldfarb DA; Flechner SM; Poggio ED; Sehgal AR
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1773-80. PubMed ID: 25237071
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis.
    Almeida CC; Silveira MR; de Araújo VE; de Lemos LL; de Oliveira Costa J; Reis CA; de Assis Acurcio F; das Gracas Braga Ceccato M
    Pharmaceuticals (Basel); 2013 Sep; 6(10):1170-94. PubMed ID: 24275847
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease.
    Mullins CD; Jain R; Weir MR; Franey CS; Shih YC; Pradel FG; Bikov K; Bartlett ST
    Transplantation; 2013 Feb; 95(3):463-9. PubMed ID: 23314351
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tolerogenic therapies in transplantation.
    Page EK; Dar WA; Knechtle SJ
    Front Immunol; 2012; 3():198. PubMed ID: 22826708
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index.
    Patibandla BK; Narra A; DeSilva R; Chawla V; Goldfarb-Rumyantzev AS
    Clin Transplant; 2012; 26(3):E307-15. PubMed ID: 22686955
    [TBL] [Abstract][Full Text] [Related]  

  • 91. If you can't comply with dialysis, how do you expect me to trust you with transplantation? Australian nephrologists' views on indigenous Australians' 'non-compliance' and their suitability for kidney transplantation.
    Anderson K; Devitt J; Cunningham J; Preece C; Jardine M; Cass A
    Int J Equity Health; 2012 Apr; 11():21. PubMed ID: 22513223
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increasing the pool of deceased donor organs for kidney transplantation.
    Schold JD; Segev DL
    Nat Rev Nephrol; 2012 Mar; 8(6):325-31. PubMed ID: 22450438
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Non-medical factors influencing access to renal transplantation.
    Vamos EP; Novak M; Mucsi I
    Int Urol Nephrol; 2009; 41(3):607-16. PubMed ID: 19350409
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage.
    Woodward RS; Page TF; Soares R; Schnitzler MA; Lentine KL; Brennan DC
    Am J Transplant; 2008 Dec; 8(12):2636-46. PubMed ID: 19032227
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Laparoscopic live donor nephrectomy: a step forward in kidney transplantation?
    Skrekas G; Papalois VE; Mitsis M; Hakim NS
    JSLS; 2003; 7(3):197-206. PubMed ID: 14558706
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Renal transplantation in the elderly.
    Cameron JS
    Int Urol Nephrol; 2000; 32(2):193-201. PubMed ID: 11229632
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?
    Epstein AM; Ayanian JZ; Keogh JH; Noonan SJ; Armistead N; Cleary PD; Weissman JS; David-Kasdan JA; Carlson D; Fuller J; Marsh D; Conti RM
    N Engl J Med; 2000 Nov; 343(21):1537-44, 2 p preceding 1537. PubMed ID: 11087884
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Increased rates of donation with laparoscopic donor nephrectomy.
    Schweitzer EJ; Wilson J; Jacobs S; Machan CH; Philosophe B; Farney A; Colonna J; Jarrell BE; Bartlett ST
    Ann Surg; 2000 Sep; 232(3):392-400. PubMed ID: 10973389
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Total nitric oxide production is low in patients with chronic renal disease.
    Schmidt RJ; Baylis C
    Kidney Int; 2000 Sep; 58(3):1261-6. PubMed ID: 10972689
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
    Coukell AJ; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.